Molecular typing is predicated on molecular genetic tests and isn't nonetheless routinely available. Molecular subtypes and immunohistochemical surrogate markers in the tumors (HR, HER2, triple detrimental) correlate in about 70%. The differentiation of luminal A and B subtypes by HR standing and proliferation markers like Ki-67 could possibly be h